Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
NIH
Sort By
Newest First
1 / 1
NIH
The White House’s War on the NIH and the Disasters Ahead
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-05
Mar 24, 2025
Federal Job Cuts
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-04
Feb 19, 2025
Financing
Statement from Aaron J. Kowalski, the Type 1 Diabetes Research and Advocacy Organization, on NIH Indirect Costs Cuts
Breakthrough T1d, Formerly Jdrf
PR-02-25-NI-10
Feb 11, 2025
NIH Funding
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-03
Feb 10, 2025
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05
Feb 08, 2022
HIV
NIH Launches New Collaboration to Develop Gene-based Cures for Sickle Cell Disease and HIV on Global Scale
National Institutes of Health (NIH)
PR-M10-19-NI-033
Oct 24, 2019
Drug Access
British Lung Cancer Patients Will Get Access to Pfizer’s Vizimpro
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-020
Jul 22, 2019
Awards
Ross Prize Awarded To NIH Scientific Director
Nice Insight
PR-M05-19-NI-049
May 16, 2019
Funding
Mymetics receives HIV Vaccine Funding from the NIH
Texas Biomed
PR-M05-19-NI-004
May 01, 2019
Clinical Study
Amygdala Neurosciences Announces Dosing the First Patients in the $12.4 Million NIH HEAL Initiative Funded SEARCH Program of Clinical Studies with ANS-6637
Amygdala Neurosciences, Inc.
PR-M04-19-NI-006
Apr 02, 2019
Innovation
NIH $1.4M Grant Supports Study into Precision Bioelectronic Medicine
Feinstein Institute
PR-M11-18-NI-057
Nov 16, 2018
Treatment
First Treatment for MERS Appears Safe in NIH Phase I Clinical Trial
SAB Biotherapeutics, Inc.
PR-M01-18-NI-041
Jan 15, 2018
Clinical Research
CRO Pharmaceutical Product Development Wins NIH Contract for HIV Research
Nice Insight
PAO-M11-17-NI-021
Nov 14, 2017
Vaccine
NIH Awards $318 Million Contract to Develop HIV Vaccine
Nice Insight
PAO-M07-17-NI-026
Jul 21, 2017
Clinical Trials
Harmonized Protocol Templates Available for Clinical Trial Sponsors
Nigel Walker
Nice Insight
PAO-M05-17-NI-013-5280
May 11, 2017
1 / 1
